Showing results 1 to 3 of 3
| Title | Author(s) | Issue Date | |
|---|---|---|---|
A Phase IIIb open-label, single-arm study of afatinib in EGFR TKI-naïve patients with EGFRm+ NSCLC: An interim analysis. Proceeding/Conference:World Lung Cancer Conference, 2017 | 2017 | ||
| 2022 | |||
| 2021 |
